Literature DB >> 32151659

Circular RNA has_circ_0003204 inhibits oxLDL-induced vascular endothelial cell proliferation and angiogenesis.

Huifang Liu1, Xirui Ma1, Ziming Mao1, Minyan Shen1, Jing Zhu1, Fengling Chen2.   

Abstract

Circular RNAs (circRNAs) are widely expressed in eukaryotic cells and play a key role in atherosclerosis. The aim of this study is to explore the relationship between hsa_circ_0003204 and atherosclerosis. Here, hsa_circ_0003204 was aberrantly overexpressed in the ox-LDL-induced human umbilical vein endothelial cells (HUVECs). Knockdown of hsa_circ_0003204 facilitated the proliferation, migration, and invasion but reduced the apoptosis of oxLDL-induced HUVECs. Furthermore, hsa_circ_0003204 knockdown significantly reduced the E-cadherin expression but increased the expressions of N-cadherin and vimentin in oxLDL-induced HUVECs. Collectively, these findings suggest that hsa_circ_0003204 plays an important role in the proliferation and angiogenesis of HUVECs, providing a potential target for treating endothelial cell damage in atherosclerosis.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Circular RNAs; circ_0003204

Mesh:

Substances:

Year:  2020        PMID: 32151659     DOI: 10.1016/j.cellsig.2020.109595

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  13 in total

1.  Circ_USP36/miR-182-5p/KLF5 axis regulates the ox-LDL-induced injury in human umbilical vein smooth muscle cells.

Authors:  Qiang Zhao; Ying-Hong Lu; Xin Wang; Xue-Jun Zhang
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

Review 2.  Insights into circular RNAs: their biogenesis, detection, and emerging role in cardiovascular disease.

Authors:  Zoe Ward; John Pearson; Sebastian Schmeier; Vicky Cameron; Anna Pilbrow
Journal:  RNA Biol       Date:  2021-03-28       Impact factor: 4.652

Review 3.  CircRNA-miRNA interactions in atherogenesis.

Authors:  Kind-Leng Tong; Ke-En Tan; Yat-Yuen Lim; Xin-Yi Tien; Pooi-Fong Wong
Journal:  Mol Cell Biochem       Date:  2022-05-23       Impact factor: 3.396

Review 4.  Interplay between circular RNA, microRNA, and human diseases.

Authors:  Bimaljeet Kour; Suruchi Gupta; Ravail Singh; Yengkhom Sophiarani; Prosenjit Paul
Journal:  Mol Genet Genomics       Date:  2022-01-27       Impact factor: 3.291

5.  circ_0003204 regulates the osteogenic differentiation of human adipose-derived stem cells via miR-370-3p/HDAC4 axis.

Authors:  Liyuan Yu; Kai Xia; Jing Zhou; Zhiai Hu; Xing Yin; Chenchen Zhou; Shujuan Zou; Jun Liu
Journal:  Int J Oral Sci       Date:  2022-06-21       Impact factor: 24.897

6.  Circ_0065149 Alleviates Oxidized Low-Density Lipoprotein-Induced Apoptosis and Inflammation in Atherosclerosis by Targeting miR-330-5p.

Authors:  Dan Li; Wen Jin; Li Sun; Jiawei Wu; Hao Hu; Likun Ma
Journal:  Front Genet       Date:  2021-02-02       Impact factor: 4.599

7.  CircUSP36 knockdown alleviates oxidized low‑density lipoprotein‑induced cell injury and inflammatory responses in human umbilical vein endothelial cells via the miR‑20a‑5p/ROCK2 axis.

Authors:  Jun Miao; Bo Wang; Ran Shao; Yan Wang
Journal:  Int J Mol Med       Date:  2021-02-12       Impact factor: 4.101

8.  Circ_0004104 knockdown alleviates oxidized low-density lipoprotein-induced dysfunction in vascular endothelial cells through targeting miR-328-3p/TRIM14 axis in atherosclerosis.

Authors:  Chi Zhang; Liyue Wang; Ying Shen
Journal:  BMC Cardiovasc Disord       Date:  2021-04-23       Impact factor: 2.298

9.  circ_0003204 Regulates Cell Growth, Oxidative Stress, and Inflammation in ox-LDL-Induced Vascular Endothelial Cells via Regulating miR-942-5p/HDAC9 Axis.

Authors:  Huan Wan; Ting You; Wei Luo
Journal:  Front Cardiovasc Med       Date:  2021-04-01

Review 10.  Circular RNA Expression: Its Potential Regulation and Function in Abdominal Aortic Aneurysms.

Authors:  Yanshuo Han; Hao Zhang; Ce Bian; Chen Chen; Simei Tu; Jiahui Guo; Yihao Wu; Dittmar Böckler; Jian Zhang
Journal:  Oxid Med Cell Longev       Date:  2021-06-29       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.